A U.S. appeals court on Monday gave Viatris' Mylan Pharmaceuticals another chance for its proposed generic of Johnson & Johnson.
https://www.reuters.com/legal/litigation/viatris-us-court-win-reopens-path-generic-jj-hypertension-drug-2023-11-06/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.